Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers

por Tré-Hardy, Marie, Cupaiolo, Roberto, Papleux, Emmanuelle, Wilmet, Alain, Horeanga, Alexandra, Antoine-Moussiaux, Thomas, Della Vecchia, Andrea, Beukinga, Ingrid, Vekemans, Marc, Blairon, Laurent
Publicado 2021

Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary

por Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Antoine-Moussiaux, Thomas, Della Vecchia, Andrea, Horeanga, Alexandra, Papleux, Emmanuelle, Vekemans, Marc, Beukinga, Ingrid, Blairon, Laurent
Publicado 2021

Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected

por Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Antoine-Moussiaux, Thomas, Coman-Vlagea, Nicoleta, Della Vecchia, Andrea, Horeanga, Alexandra, Papleux, Emmanuelle, Vekemans, Marc, Beukinga, Ingrid, Blairon, Laurent
Publicado 2022